DaVita Stock: Is Wall Street Bullish or Bearish?

DaVita Inc. (DVA) is a leading healthcare provider specializing in kidney care services, including dialysis treatments for patients with chronic kidney failure. Headquartered in Denver, Colorado, it operates outpatient centers worldwide. The company has a market capitalization of $9.94 billion. 

DaVita’s stock has been under pressure over the past year due to rising costs, exacerbated by a ransomware attack that resulted in a data breach affecting 2.7 million individuals. Over the past 52 weeks, the stock has declined 18.2%. However, after reporting strong quarterly results, it is up 24% year-to-date (YTD). DaVita’s shares had reached a 52-week low of $101 on Jan. 14, but are up 39.4% from that level.